114 related articles for article (PubMed ID: 18050128)
1. Retinal angiomatous proliferation reactivation 6 months after high-dose intravitreal acetonide triamcinolone and photodynamic therapy.
Reche-Frutos J; Calvo-Gonzalez C; Donate-Lopez J; Garcia-Feijoo J; Saenz-Frances F; Fernandez-Perez C; Garcia-Sanchez J
Eur J Ophthalmol; 2007; 17(6):979-82. PubMed ID: 18050128
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
Saito M; Shiragami C; Shiraga F; Kano M; Iida T
Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
[TBL] [Abstract][Full Text] [Related]
3. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.
Freund KB; Klais CM; Eandi CM; Ober MD; Goldberg DE; Sorenson JA; Yannuzzi LA
Arch Ophthalmol; 2006 Apr; 124(4):487-92. PubMed ID: 16606873
[TBL] [Abstract][Full Text] [Related]
4. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
5. Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.
Krebs I; Krepler K; Stolba U; Goll A; Binder S
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):237-43. PubMed ID: 17674018
[TBL] [Abstract][Full Text] [Related]
6. Retinal angiomatous proliferation treated with a combination of intravitreal triamcinolone acetonide and photodynamic therapy with verteporfin.
Mantel I; Ambresin A; Zografos L
Eur J Ophthalmol; 2006; 16(5):705-10. PubMed ID: 17061221
[TBL] [Abstract][Full Text] [Related]
7. Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP).
Sutter FK; Kurz-Levin MM; Fleischhauer J; Bösch MM; Barthelmes D; Helbig H
Klin Monbl Augenheilkd; 2006 May; 223(5):376-8. PubMed ID: 16705508
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
Iwama D; Otani A; Sasahara M; Yodoi Y; Gotoh N; Tamura H; Tsujikawa A; Yoshimura N
Br J Ophthalmol; 2008 Oct; 92(10):1352-6. PubMed ID: 18662914
[TBL] [Abstract][Full Text] [Related]
9. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.
Krebs I; Binder S; Stolba U
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):863-7. PubMed ID: 16331486
[TBL] [Abstract][Full Text] [Related]
10. The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation.
Bearelly S; Espinosa-Heidmann DG; Cousins SW
Br J Ophthalmol; 2008 Feb; 92(2):191-6. PubMed ID: 17962393
[TBL] [Abstract][Full Text] [Related]
11. Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone.
van de Moere A; Kak R; Sandhu SS; Talks SJ
Am J Ophthalmol; 2007 Apr; 143(4):701-4. PubMed ID: 17386286
[TBL] [Abstract][Full Text] [Related]
12. Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
Nicolò M; Ghiglione D; Lai S; Calabria G
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1336-8. PubMed ID: 16523293
[TBL] [Abstract][Full Text] [Related]
13. One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.
Shirakata Y; Shiragami C; Yamashita A; Nitta E; Fujiwara A; Shiraga F
Jpn J Ophthalmol; 2012 Nov; 56(6):599-607. PubMed ID: 22990616
[TBL] [Abstract][Full Text] [Related]
14. Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angiomatous proliferation.
Boscia F; Furino C; Prascina F; Delle Noci N; Sborgia L; Sborgia C
Eur J Ophthalmol; 2005; 15(4):513-6. PubMed ID: 16001389
[TBL] [Abstract][Full Text] [Related]
15. [Combined intravitreal triamcinolone and photodynamic therapy for retinal angiomatous proliferation after photodynamic therapy].
Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R
Nippon Ganka Gakkai Zasshi; 2008 Apr; 112(4):361-70. PubMed ID: 18444415
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
17. Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
Arevalo JF; Sanchez JG; Garcia RA; Wu L; Berrocal MH; Rodriguez FJ; Rodríguez A; Novoa LA; Garcia-Amaris R
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1673-80. PubMed ID: 17619895
[TBL] [Abstract][Full Text] [Related]
18. Retinal angiomatous proliferation: clinical characteristics and treatment options.
Hunter MA; Dunbar MT; Rosenfeld PJ
Optometry; 2004 Sep; 75(9):577-88. PubMed ID: 15481226
[TBL] [Abstract][Full Text] [Related]
19. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
20. Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.
Iriyama A; Obata R; Inoue Y; Takahashi H; Tamaki Y; Yanagi Y
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):339-44. PubMed ID: 17805556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
